Immunome IMNM
NASDAQ IMNM
$18.11 +0.19 (+1.06%)
As of: Oct 21, 2026 · 1:54 PM EDT

Immunome (IMNM) Net Margin (2020 - 2025)

Updated

Immunome (IMNM) recorded Net Margin of -3059.99% in FY2025, up 180.39 percentage points from -3240.38% in FY2024.

Analysis

Immunome (IMNM) Net Margin (2020 - 2025) Analysis & Trends

  • Per Business Quant data, IMNM's Net Margin was -3240.38% in FY2024 (-2478.46 pp) and -761.92% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,134.24 Bn 1,102.83 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 616.05 Bn 534.58 Bn 17.26 Bn 21.86%
3 AbbVie 500.90 Bn 474.01 Bn 12.70 Bn 21.27%
4 Merck 367.17 Bn 321.54 Bn 12.21 Bn -8.04%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn 16.30%
7 Amgen 235.77 Bn 191.17 Bn 7.24 Bn 23.62%
8 Gilead Sciences 190.70 Bn 164.90 Bn 6.22 Bn -134.51%
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn -1.65%
10 Immunome 2.05 Bn 23.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1,080.87%
Mar 31, 2025 -1,423.10%
Dec 31, 2024 -2,930.93%
Sep 30, 2024 -1,618.56%
Jun 30, 2024 -1,528.00%
Mar 31, 2024 -12,584.26%
Dec 31, 2023 -2,421.17%
Sep 30, 2023 -121.88%
Jun 30, 2023 -130.35%
Mar 31, 2023 -180.63%
Dec 31, 2022 -778,600.00%
Sep 30, 2022 -915,500.00%
Jun 30, 2022 -446,200.00%
Mar 31, 2022 -1,170,000.00%
Jun 30, 2020 -54,200.00%
API Access

Immunome Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=IMNM&period=max&api_key=YOUR_API_KEY